Understanding Pain-O-Soma
Pain-O-Soma 350mg is a carisoprodol-based muscle relaxant compound manufactured by HAB Pharmaceuticals for controlled research applications. Carisoprodol is a centrally acting skeletal muscle relaxant that researchers investigate for its mechanisms of action on muscle spasm conditions and neuromuscular pathways. This formulation provides standardised 350mg dosing units suitable for pharmacokinetic studies and comparative research protocols examining muscle relaxation mechanisms.
Laboratory Applications
Researchers utilise carisoprodol preparations to study muscle relaxant pharmacology and central nervous system modulation pathways. Studies examine the compound’s conversion to meprobamate and its effects on GABAergic neurotransmission in controlled experimental settings. Academic institutions investigate carisoprodol’s binding affinity profiles and duration of action through systematic research protocols. The HAB Pharmaceuticals formulation enables consistent dosing parameters for comparative studies examining muscle relaxant efficacy across different research models.
Product Specifications
| Parameter | Value |
|---|---|
| Active Compound | Carisoprodol |
| Strength | 350mg per tablet |
| Manufacturer | HAB Pharmaceuticals |
| Form | Oral tablets |
| Storage | Room temperature, dry conditions |
| Research Classification | Muscle relaxant compound |
Laboratory researchers conducting muscle relaxant studies benefit from accessing diverse research compounds through Stroid UK Shop that maintain comprehensive inventories. The carisoprodol research category provides specialised muscle relaxant compounds for systematic investigation. Comparative studies often examine muscle relaxants alongside other research areas including selective androgen receptor modulators and peptide research compounds to understand broader therapeutic mechanisms.
Research Compliance
Pain-O-Soma 350mg tablets are supplied exclusively for laboratory research purposes and in-vitro studies. This product is not intended for human consumption, therapeutic use, or self-administration. Researchers must maintain appropriate laboratory protocols and institutional approvals when conducting carisoprodol studies. All research applications should follow established scientific methodologies and regulatory guidelines for controlled substance research investigations.
